Fig. 2From: Efficacy and safety of adding rivaroxaban to the anti-platelet regimen in patients with coronary artery disease: a systematic review and meta-analysis of randomized controlled trialsOutcomes assessing efficacy with the addition of rivaroxaban in patients with coronary artery diseaseBack to article page